Catalyst Wire Dossier Catalyst Wire Dossier

IPdR

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPdR, covering 2023-10-05 to 2023-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer [Phase 1]

See pricing